Zobrazeno 1 - 10
of 579
pro vyhledávání: '"Cardiac risk factors and prevention"'
Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality
Autor:
Hernandez, Adrian V., Emonds, Erin E., Chen, Brett A., Zavala-Loayza, Alfredo J., Thota, Priyaleela, Pasupuleti, Vinay, Roman, Yuani M., Bernabe-Ortiz, Antonio, Miranda, J. Jaime
Publikováno v:
Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Academico - UPCHeart.
Objective A systematic review and meta-analysis was conducted to assess the efficacy of low-sodium salt substitutes (LSSS) as a potential intervention to reduce cardiovascular (CV) diseases. Methods Five engines and ClinicalTrials.gov were searched f
Externí odkaz:
http://hdl.handle.net/10757/652462
Publikováno v:
Frontiers in Physiology, Vol 9 (2019)
Objective: The present meta-analysis was aimed to systematically evaluate the effectiveness and accuracy of brain natriuretic peptide (BNP), cardiac troponin (cTn), high sensitive C reactive protein (hs-CRP) and CRP for predicting postoperative major
Externí odkaz:
https://doaj.org/article/fa9c79fe03cf4528a3cebe92c86c29d6
Autor:
Sheona McHale, Aynsley Cowie, Sarah Brown, Tom Butler, Kathryn Carver, Hasnain M Dalal, Susan Dawkes, Carolyn Deighan, Patrick Doherty, Jo Evans, Sally Hinton, Jennifer Jones, Joseph Mills, Simon Nichols, Rod S Taylor
ObjectiveThe purpose of this British Association for Cardiovascular Prevention and Rehabilitation (BACPR) research priority setting project (PSP) was to identify a top 10 list of priority research questions for cardiovascular prevention and rehabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ac97d40d467536a28d38677e0a5677
Autor:
Roberto Manfredini, Giustino Parruti, Lorenzo G. Mantovani, Cecilia Acuti Martellucci, Lamberto Manzoli, Rosaria Cappadona, Maria Elena Flacco, Alfonso Mascitelli, Francesca Bravi
Publikováno v:
Heart
ObjectiveIt has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational studies varied, and summary
Autor:
Scott D. Berkowitz, John W. Eikelboom, Victor Aboyans, Petr Widimsky, Stuart J. Connolly, Eva Muehlhofer, Gilles R. Dagenais, Salim Yusuf, Keith A.A. Fox, Leanne Dyal, Deepak L. Bhatt, Jeffrey L. Probstfield, Bernhard R Winkelmann, Jacqueline Bosch, Darryl P. Leong
Publikováno v:
Heart
ObjectiveIn patients with chronic coronary or peripheral artery disease enrolled in the Cardiovascular Outcomes for People Using Anticoagulation Strategies trial, randomised antithrombotic treatments were stopped after a median follow-up of 23 months
Autor:
Mauricio Lima Barreto, Sanjay Kinra, Elizabeth Williamson, Poppy Alice Carson Mallinson, Shammi Luhar
Publikováno v:
Heart. 107:822-827
BackgroundIt has been suggested that cardiovascular disease exhibits a ‘social cross-over’, from greater risk in higher socioeconomic groups to lower socioeconomic groups, on economic development, but robust evidence is lacking. We used standardi
Publikováno v:
Heart
ObjectivePrevious studies that evaluated cardiovascular risk factors considered age as a potential confounder. We aimed to investigate the impact of cardiovascular disease (CVD) and its risk factors on fatal outcomes according to age in patients with
Autor:
Krishnan Bhaskaran, Alexander R. Lyon, Susannah Stanway, Jennifer L. Lund, Liam Smeeth, Sharon Peacock Hinton, Anthony Matthews
Publikováno v:
Heart
ObjectiveExamine the effect of tamoxifen and aromatase inhibitors (AIs) on the risk of 12 clinically relevant cardiovascular outcomes in postmenopausal female breast cancer survivors.MethodsWe carried out two prospective cohort studies among postmeno
Publikováno v:
Heart
ObjectiveEthnic differences in cardiovascular disease incidence, but not cardiovascular disease recurrence, are reported. We characterised long-term risk of major adverse cardiovascular event (MACE) and mortality following a non-fatal cardiovascular
Autor:
Samuel Heuts, Peyman Sardari Nia, Kinga Kosiorowska, Sebastiaan C.A.M. Bekkers, Mikolaj Berezowski, Heleen J. Bouman, Joachim E. Wildberger, Jules R. Olsthoorn, Jos G. Maessen, Bartosz Rylski, Bouke P Adriaans, Simon Schalla, Harry J.G.M. Crijns, Casper Mihl, Ehsan Natour
Publikováno v:
Heart, 106(12), 892-897. BMJ Publishing Group
ObjectiveManagement of thoracic aortic aneurysms (TAAs) comprises regular diameter follow-up until the indication criterion for prophylactic surgery is reached. However, this approach is unable to predict the majority of acute type A aortic dissectio